TrialAntimicrobial agents and chemotherapy2000

A double-blind placebo-controlled study of an infusion of lexipafant (Platelet-activating factor receptor antagonist) in patients with severe sepsis.

Y Suputtamongkol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.